Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Sep 15;98(6):1373–1380. doi: 10.1172/JCI118924

Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.

J B Lefkowith 1, M Kiehl 1, J Rubenstein 1, R DiValerio 1, K Bernstein 1, L Kahl 1, R L Rubin 1, M Gourley 1
PMCID: PMC507563  PMID: 8823302

Abstract

We used an ELISA employing extracts of human glomerular basement membrane (GBM) to detect, characterize, and evaluate the clinical significance of glomerular-binding IgG in patients with SLE nephritis. Most patients with SLE nephritis exhibited GBM-binding IgG, although many patients with active nonrenal SLE or symptomatic, drug-induced lupus had similar reactivity, albeit at lower levels. IgG binding to GBM in SLE nephritis patients was decreased by DNase pretreatment of GBM, restored after DNase with nuclear antigens (most notably with nucleosomes), inhibited by exogenous nuclear antigens (particularly nucleosomes), but unaffected by exposure of serum to DNase/high ionic strength. The characteristics of IgG binding to GBM largely paralleled the patients' underlying autoimmune response, which was dominated either by antibodies to DNA/nucleosomes or to nucleosomes alone. Binding of lupus sera to nonrenal extracellular matrix (even with nucleosomes) was not equivalent to GBM. Collagenase pretreatment of GBM variably decreased IgG binding, depending on the level and type of binding. SLE nephritis patients with high levels of GBM-binding IgG exhibited more severe disease clinically, but the same renal histopathology, as patients with lower levels. The level of GBM-binding IgG at presentation did not predict the therapeutic response, but decreased in responders to therapy. In sum, glomerular-binding IgG in lupus nephritis binds to epitopes on chromatin, which adheres to GBM in part via collagen. These autoantibodies appear necessary, but not sufficient, for the development of nephritis, and correlate with clinical rather than histopathologic parameters of disease activity.

Full Text

The Full Text of this article is available as a PDF (268.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J. F., Jacob L. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 1994 Nov;37(11):1684–1688. doi: 10.1002/art.1780371118. [DOI] [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appel A. E., Sablay L. B., Golden R. A., Barland P., Grayzel A. I., Bank N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med. 1978 Feb;64(2):274–283. doi: 10.1016/0002-9343(78)90056-6. [DOI] [PubMed] [Google Scholar]
  4. Bell D. A., Morrison B., VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest. 1990 May;85(5):1487–1496. doi: 10.1172/JCI114595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bernstein K. A., Bolshoun D., Lefkowith J. B. Serum glomerular binding activity is highly correlated with renal disease in MRL/lpr mice. Clin Exp Immunol. 1993 Sep;93(3):418–423. doi: 10.1111/j.1365-2249.1993.tb08194.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bernstein K. A., Kahl L. E., Balow J. E., Lefkowith J. B. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity. Clin Exp Immunol. 1994 Oct;98(1):60–65. doi: 10.1111/j.1365-2249.1994.tb06607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bernstein K. A., Valerio R. D., Lefkowith J. B. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol. 1995 Mar 1;154(5):2424–2433. [PubMed] [Google Scholar]
  8. Bernstein K., Bolshoun D., Gilkeson G., Munns T., Lefkowith J. B. Detection of glomerular-binding immune elements in murine lupus using a tissue-based ELISA. Clin Exp Immunol. 1993 Mar;91(3):449–455. doi: 10.1111/j.1365-2249.1993.tb05923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bradley D. S., Jennette J. C., Cohen P. L., Eisenberg R. A. Chronic graft versus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci. J Immunol. 1994 Feb 15;152(4):1960–1969. [PubMed] [Google Scholar]
  10. Brinkman K., Termaat R. M., de Jong J., van den Brink H. G., Berden J. H., Smeenk R. J. Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol. 1989 Jun-Aug;140(5-6):595–612. doi: 10.1016/0923-2494(89)90122-3. [DOI] [PubMed] [Google Scholar]
  11. Burlingame R. W., Boey M. L., Starkebaum G., Rubin R. L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994 Jul;94(1):184–192. doi: 10.1172/JCI117305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burlingame R. W., Rubin R. L., Balderas R. S., Theofilopoulos A. N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993 Apr;91(4):1687–1696. doi: 10.1172/JCI116378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Burlingame R. W., Rubin R. L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 1990 Dec 5;134(2):187–199. doi: 10.1016/0022-1759(90)90380-e. [DOI] [PubMed] [Google Scholar]
  14. Chabre H., Amoura Z., Piette J. C., Godeau P., Bach J. F., Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1995 Oct;38(10):1485–1491. doi: 10.1002/art.1780381015. [DOI] [PubMed] [Google Scholar]
  15. Di Valerio R., Bernstein K. A., Varghese E., Lefkowith J. B. Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism. J Immunol. 1995 Aug 15;155(4):2258–2268. [PubMed] [Google Scholar]
  16. Ebling F., Hahn B. H. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum. 1980 Apr;23(4):392–403. doi: 10.1002/art.1780230402. [DOI] [PubMed] [Google Scholar]
  17. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994 Apr 1;152(7):3685–3692. [PubMed] [Google Scholar]
  18. Faaber P., Rijke T. P., van de Putte L. B., Capel P. J., Berden J. H. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest. 1986 Jun;77(6):1824–1830. doi: 10.1172/JCI112508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Foster M. H., Sabbaga J., Line S. R., Thompson K. S., Barrett K. J., Madaio M. P. Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse. J Immunol. 1993 Jul 15;151(2):814–824. [PubMed] [Google Scholar]
  20. Gilkeson G. S., Bernstein K., Pippen A. M., Clarke S. H., Marion T., Pisetsky D. S., Ruiz P., Lefkowith J. B. The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol. 1995 Jul;76(1 Pt 1):59–67. doi: 10.1006/clin.1995.1088. [DOI] [PubMed] [Google Scholar]
  21. Hecht B., Siegel N., Adler M., Kashgarian M., Hayslett J. P. Prognostic indices in lupus nephritis. Medicine (Baltimore) 1976 Mar;55(2):163–181. doi: 10.1097/00005792-197603000-00005. [DOI] [PubMed] [Google Scholar]
  22. Izui S., Kelley V. E., Masuda K., Yoshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984 Jul;133(1):227–233. [PubMed] [Google Scholar]
  23. Jacob L., Lety M. A., Louvard D., Bach J. F. Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest. 1985 Jan;75(1):315–317. doi: 10.1172/JCI111692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jacob L., Viard J. P., Allenet B., Anin M. F., Slama F. B., Vandekerckhove J., Primo J., Markovits J., Jacob F., Bach J. F. A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4669–4673. doi: 10.1073/pnas.86.12.4669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Koffler D., Schur P. H., Kunkel H. G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967 Oct 1;126(4):607–624. doi: 10.1084/jem.126.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kramers C., Hylkema M. N., van Bruggen M. C., van de Lagemaat R., Dijkman H. B., Assmann K. J., Smeenk R. J., Berden J. H. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest. 1994 Aug;94(2):568–577. doi: 10.1172/JCI117371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lefkowith J. B., Gilkeson G. S. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 1996 Jun;39(6):894–903. doi: 10.1002/art.1780390605. [DOI] [PubMed] [Google Scholar]
  29. Lloyd W., Schur P. H. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 1981 May;60(3):208–217. doi: 10.1097/00005792-198105000-00004. [DOI] [PubMed] [Google Scholar]
  30. Madaio M. P., Carlson J., Cataldo J., Ucci A., Migliorini P., Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol. 1987 May 1;138(9):2883–2889. [PubMed] [Google Scholar]
  31. Malide D., Londoño I., Russo P., Bendayan M. Ultrastructural localization of DNA in immune deposits of human lupus nephritis. Am J Pathol. 1993 Jul;143(1):304–311. [PMC free article] [PubMed] [Google Scholar]
  32. Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. doi: 10.1084/jem.177.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Monestier M., Novick K. E., Karam E. T., Chabanne L., Monier J. C., Rigal D. Autoantibodies to histone, DNA and nucleosome antigens in canine systemic lupus erythematosus. Clin Exp Immunol. 1995 Jan;99(1):37–41. doi: 10.1111/j.1365-2249.1995.tb03469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ohnishi K., Ebling F. M., Mitchell B., Singh R. R., Hahn B. H., Tsao B. P. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol. 1994 Jun;6(6):817–830. doi: 10.1093/intimm/6.6.817. [DOI] [PubMed] [Google Scholar]
  35. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol. 1992;27(1-2):93–127. doi: 10.3109/10409239209082560. [DOI] [PubMed] [Google Scholar]
  36. Raz E., Brezis M., Rosenmann E., Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol. 1989 May 1;142(9):3076–3082. [PubMed] [Google Scholar]
  37. Rubin R. L., Bell S. A., Burlingame R. W. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest. 1992 Jul;90(1):165–173. doi: 10.1172/JCI115832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rubin R. L., Burlingame R. W., Arnott J. E., Totoritis M. C., McNally E. M., Johnson A. D. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. J Immunol. 1995 Mar 1;154(5):2483–2493. [PubMed] [Google Scholar]
  39. Schmiedeke T. M., Stöckl F. W., Weber R., Sugisaki Y., Batsford S. R., Vogt A. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med. 1989 Jun 1;169(6):1879–1894. doi: 10.1084/jem.169.6.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schmiedeke T., Stoeckl F., Muller S., Sugisaki Y., Batsford S., Woitas R., Vogt A. Glomerular immune deposits in murine lupus models may contain histones. Clin Exp Immunol. 1992 Dec;90(3):453–458. doi: 10.1111/j.1365-2249.1992.tb05867.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Stöckl F., Muller S., Batsford S., Schmiedeke T., Waldherr R., Andrassy K., Sugisaki Y., Nakabayashi K., Nagasawa T., Rodriguez-Iturbe B. A role for histones and ubiquitin in lupus nephritis? Clin Nephrol. 1994 Jan;41(1):10–17. [PubMed] [Google Scholar]
  42. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  43. Tax W. J., Kramers C., van Bruggen M. C., Berden J. H. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int. 1995 Sep;48(3):666–673. doi: 10.1038/ki.1995.336. [DOI] [PubMed] [Google Scholar]
  44. Vlahakos D. V., Foster M. H., Adams S., Katz M., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992 Jun;41(6):1690–1700. doi: 10.1038/ki.1992.242. [DOI] [PubMed] [Google Scholar]
  45. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M., Seldin M. F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 1;176(6):1645–1656. doi: 10.1084/jem.176.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yoshida H., Kohno A., Ohta K., Hirose S., Maruyama N., Shirai T. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice. J Immunol. 1981 Aug;127(2):433–437. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES